Dinalbuphine Ester (Naldebain) for Pain Management After Cesarean Section

Clinical trial NCT06344169 · RECRUITING

Trial details

NCT number: NCT06344169
Sponsor: Dalin Tzu Chi General Hospital
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Postsurgical Pain Cesarean Section Chronic Post-surgical Pain

Start date: 2024-05-06
Primary completion: 2026-03-14
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.